Latest Breaking News On - Kardium inc - Page 1 : comparemela.com

Kardium enters pulsed field ablation market with $104M financing

Kardium Inc. landed $104 million in new financing for its Globe mapping and ablation system for atrial fibrillation, positioning it to enter the rapidly changing field in the U.S. The funds will allow the company to finish its PULSAR trial, secure FDA approval and launch its pulsed field ablation system commercially, Kardium Chief Financial Officer Koert VandenEnden told BioWorld.

Koert vandenendenKardium incKardium chief financial officer koert vandenenden

B.C. medical tech company Kardium secures US$104M in funding - BC News

A B.C. medical device company specializing in helping out heartbeats is keeping capital flowing through its corporate system.

GermanyVancouverBritish columbiaCanadaUnited statesAmericanDoug goertzenKevin chaplinRob kruytT rowe price associates incFidelity management research companyKardium incT rowe price investment management incFidelity managementResearch companyGlobe mapping

Kardium raises US$104M to take on irregular heartbeats - Bowen Island Undercurrent

Vancouver, B.C., medical device company has developed Globe Mapping and Ablation System

GermanyVancouverBritish columbiaCanadaUnited statesAmericanKevin chaplinT rowe price investment management incFidelity management research companyT rowe price associates incKardium incFidelity managementResearch companyGlobe mappingAblation systemGlobe system

Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe® System, showing promise for improving the treatment of atrial fibrillation

Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe® System, showing promise for improving the treatment of atrial fibrillation
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

United kingdomCanadaVancouverBritish columbiaBritishStefan avallKevin chaplinKardium incPulsed fieldClinical effectivenessProcedural safetyProcedural workflowGlobe systemProduct management

Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study

VANCOUVER, British Columbia, April 02, 2024 Kardium Inc., a private medical device company that has developed the Globe® System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today the successful completion of enrollment in the paroxysmal cohort of the pivotal PULSAR IDE (Investigational Device Exemption) study. This achievement marks a significant milestone in the journey to bring this groundbreaking technology to patients in the United States, with

VancouverBritish columbiaCanadaUnited statesMontrealQuebecNew yorkUnited kingdomBritishKevin chaplinStefan avallVivek reddyKardium incMcgill university health centreDrug administrationInvestigational device exemption